2 news items
Immunocore presented two posters at CROI 2024
IMCR
5 Mar 24
with human immunodeficiency virus (HIV) and hepatitis B virus (HBV). The Company aims to achieve sustained control of HIV after people living with HIV stop
Immunocore reports fourth quarter and full year 2023 financial results and provides a business update
BMY
IMCR
28 Feb 24
to a revenue-generating, sustainable company," said Bahija Jallal, CEO of Immunocore. "We look forward to the next 5 years, when we
- Prev
- 1
- Next